Aim: The purpose of the current study was to determine whether copper nanoparticles (Cu-NPs) can induce the release of proinflammatory mediators that influence the restrictive characteristics of the blood-brain barrier.
Material & Methods: Confluent rat brain microvessel endothelial cells (rBMECs) were treated with well-characterized Cu-NPs (40 or 60 nm). Cytotoxicity of the Cu-NPs was evaluated by cell proliferation assay (1.5-50 µg/ml). The extracellular concentrations of proinflammatory mediators (IL-1β, IL-2, TNF-α and prostaglandin E(2)) were evaluated by ELISA.
Results: The exposure of Cu-NPs at low concentrations increases cellular proliferation of rBMECs, by contrast, high concentrations induce toxicity. Prostaglandin E(2) release was significantly increased (threefold; 8 h) for Cu-NPs (40 and 60 nm). The extracellular levels of both TNF-α and IL-1β were significantly elevated following exposure to Cu-NPs. The P-apparent ratio, as an indicator of increased permeability of rBMEC was approximately twofold for Cu-NPs (40 and 60 nm).
Conclusion: These data suggest that Cu-NPs can induce rBMEC, proliferation at low concentrations and/or induce blood-brain barrier toxicity and potential neurotoxicity at high concentrations.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2217/nnm.11.154 | DOI Listing |
RSC Adv
January 2025
School of Chemistry and Molecular Engineering, East China University of Science and Technology 130 Meilong Road Shanghai 200237 China.
The hydrogenation of carbon dioxide into profitable chemicals is a viable path toward achieving the objective of carbon neutrality. However, the typical approach for hydrogenation of CO heavily relies on thermally driven catalysis at high temperatures, which is not aligned with the goals of carbon neutrality. Thus, there is a critical need to explore new catalytic methods for the high-efficiency conversion of CO.
View Article and Find Full Text PDFJ Mater Chem B
January 2025
Department of Biochemistry and Molecular Biology, School of Life Sciences, Central South University, Changsha, 410012, China.
Combination of immunotherapy and photothermal therapy (PTT) provides a promising therapeutic performance for tumors. However, it still faces negative feedback from suppressive factors such as adenosine. Herein, we developed a new nanodrug that can combine adenosine blockade and ferroptosis to promote the photoimmunotherapy of triple negative breast cancer (TNBC).
View Article and Find Full Text PDFBMC Microbiol
January 2025
Clinical microbiology and immunology department, National liver institute, Menoufia University, Shibin el Kom, Egypt.
Background: Recent advances in nanomedicine have derived novel prospects for development of various bioactive nanoparticles and nanocomposites with significant antibacterial and antifungal properties. This study aims to investigate some characteristics of the novel Se-NPs/CuO nanocomposite such as morphological, physicochemical, and optical properties, as well as to assess the antibacterial activity of this fabricated composite in different concentrations against some MDR Gram-positive and Gram-negative clinical bacterial isolates.
Methods: The Se-NPs/CuO nanocomposite was fabricated using the chemical deposition method.
Nat Commun
January 2025
Energy Storage Research Department, Korea Institute of Energy Research (KIER), Daejeon, 34129, Republic of Korea.
Zinc (Zn)-based batteries have been persistently challenged by the critical issue of inhomogeneous zinc deposition/stripping process on substrate surface. Herein, we reveal that zinc electrodeposition behaviors dramatically improved through the introduction of highly zincophilic copper oxide nanoparticles (CuO NPs). Strong electronic redistribution between Zn and CuO explains the high Zn affinity on CuO, with negligible nucleation overpotential.
View Article and Find Full Text PDFAnal Chim Acta
February 2025
College of Food Science and Technology, Henan Key Laboratory of Cereal and Oil Food Safety Inspection and Control, Henan University of Technology, Zhengzhou, 450001, China.
Background: Aflatoxin B1 (AFB1) is a secondary metabolite produced by Aspergillus flavus and Aspergillus parasiticus. This toxin is highly carcinogenic and toxic, posing a serious threat to human and animal health. AFB1 primarily enters the human body through contaminated food, particularly peanuts, corn, nuts, and wheat.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!